Get the Stockscreener App
2.15
1.90%
0.04
Hillevax Inc stock is traded at $2.15, with a volume of 56,235.
It is up +1.90% in the last 24 hours and up +8.04% over the past month.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
See More
Previous Close:
$2.11
Open:
$2.11
24h Volume:
56,235
Relative Volume:
0.21
Market Cap:
$107.80M
Revenue:
-
Net Income/Loss:
$-123.57M
P/E Ratio:
-0.7072
EPS:
-3.04
Net Cash Flow:
$-97.53M
1W Performance:
+2.38%
1M Performance:
+8.04%
6M Performance:
+8.04%
1Y Performance:
+14.36%
1-Day Range:
$2.10
$2.16
1-Week Range:
$2.07
$2.17
52-Week Range:
$1.34
$2.17
Hillevax Inc Stock (HLVX) Company Profile
Name
Hillevax Inc
Sector
Industry
Phone
(617) 213-5054
Address
321 HARRISON AVE, SUITE 500, BOSTON
Compare HLVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HLVX
Hillevax Inc
|
2.15 | 106.71M | 0 | -123.57M | -97.53M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.52 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.69 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
344.44 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
604.08 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
302.43 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Hillevax Inc Stock (HLVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-09-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-09-24 | Downgrade | Stifel | Buy → Hold |
| Jul-08-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-23 | Initiated | H.C. Wainwright | Buy |
View All
Hillevax Inc Stock (HLVX) Latest News
Applying big data sentiment scoring on HilleVax Inc.Pattern Recognition Based Market Move Prediction - Newser
What makes HilleVax Inc. stock price move sharplyTechnical Confirmation System with Signal Alerts - Newser
Market reaction to HilleVax Inc.’s recent newsSecure Entry Point Finder with Analysis - Newser
How HBANM stock compares to its top competitorsIs HilleVax Inc. stock undervalued or overvalued nowTechnical Insight Guide for Safer Trades - Newser
Has HilleVax Inc. found a price floorSmart Swing Picks with Confirmed Signals - Newser
Will HilleVax Inc. stock recover after recent dropLow Drawdown Stock Screener with Analysis - Newser
Top Risks to Consider Before Buying HilleVax Inc. StockStock Entry Point Planner with Volume Spike - Newser
Short Interest Drops in HilleVax Inc. After RallyConsistent Income Focused Trade List Analyzed - metal.it
Can volume confirm reversal in HilleVax Inc.Price Action Trading with Volume Confirmation - Newser
How does HilleVax Inc. generate profit in a changing economyAdvanced Screener Target Finder With High Returns - jammulinksnews.com
Analysts Apply Wyckoff Model to HilleVax Inc. StockReal Time Trade Opportunity Alerts Monitor Market Surges - beatles.ru
What catalysts could drive HilleVax Inc. stock higher in 2025Exceptional stock performance - jammulinksnews.com
How HBANM stock compares to its top competitorsIs HilleVax Inc. stock undervalued or overvalued now Real-Time Signal Tracking with Entry Level - Newser
How many analysts rate HilleVax Inc. as a “Buy”Discover undervalued opportunities early - jammulinksnews.com
What is HilleVax Inc. company’s growth strategyBuild a portfolio that outperforms the market - jammulinksnews.com
Is HilleVax Inc. a Top Dividend Stock to Watch in 2025Investor Friendly Risk Reward - metal.it
New Product Launches: Will They Boost HilleVax Inc. Stock in 2025Secure Your Capital Strategy - metal.it
HilleVax Inc. Stock Performance After Earnings: Historical InsightsWatchlist Winner Update - Newser
Why HilleVax Inc. stock attracts strong analyst attentionFree Smart Money Stock Analysis - Newser
How HilleVax Inc. stock performs during market volatilityGrowth Stock Monitor - Newser
Is HilleVax Inc. a good long term investmentConsistently outstanding ROI - PrintWeekIndia
What analysts say about HilleVax Inc. stockConsistently exceptional gains - Autocar Professional
What drives HilleVax Inc. stock priceConsistently high yield - jammulinksnews.com
What drives FPAY stock priceAccelerated earnings growth - jammulinksnews.com
HilleVax Inc. Stock Analysis and ForecastHigh-profit capital plays - jammulinksnews.com
Hillevax Inc Stock (HLVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hillevax Inc Stock (HLVX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT | See Remarks |
Feb 11 '25 |
Sale |
1.76 |
11,901 |
21,003 |
1,101,498 |
| Maltbie Shane | Chief Financial Officer |
Feb 11 '25 |
Sale |
1.76 |
4,345 |
7,659 |
79,887 |
| Maltbie Shane | Chief Financial Officer |
Feb 04 '25 |
Sale |
1.89 |
3,946 |
7,458 |
84,232 |
0.76%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):